GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Formosa Laboratories Inc (TPE:4746) » Definitions » EV-to-EBITDA

Formosa Laboratories (TPE:4746) EV-to-EBITDA : 10.93 (As of Jun. 01, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Formosa Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Formosa Laboratories's enterprise value is NT$10,332 Mil. Formosa Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was NT$945 Mil. Therefore, Formosa Laboratories's EV-to-EBITDA for today is 10.93.

The historical rank and industry rank for Formosa Laboratories's EV-to-EBITDA or its related term are showing as below:

TPE:4746' s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.76   Med: 12.29   Max: 105
Current: 10.93

During the past 13 years, the highest EV-to-EBITDA of Formosa Laboratories was 105.00. The lowest was -15.76. And the median was 12.29.

TPE:4746's EV-to-EBITDA is ranked better than
59.73% of 735 companies
in the Drug Manufacturers industry
Industry Median: 14.08 vs TPE:4746: 10.93

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-01), Formosa Laboratories's stock price is NT$70.60. Formosa Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$3.110. Therefore, Formosa Laboratories's PE Ratio (TTM) for today is 22.70.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Formosa Laboratories EV-to-EBITDA Historical Data

The historical data trend for Formosa Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Laboratories EV-to-EBITDA Chart

Formosa Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.16 6.17 13.70 21.73 14.01

Formosa Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.89 17.44 14.78 14.01 10.23

Competitive Comparison of Formosa Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Formosa Laboratories's EV-to-EBITDA falls into.


;
;

Formosa Laboratories EV-to-EBITDA Calculation

Formosa Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=10331.800/944.892
=10.93

Formosa Laboratories's current Enterprise Value is NT$10,332 Mil.
Formosa Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$945 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formosa Laboratories  (TPE:4746) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Formosa Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=70.60/3.110
=22.70

Formosa Laboratories's share price for today is NT$70.60.
Formosa Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Formosa Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Formosa Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Formosa Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 36-1, Hoping Street, Louchu, Taoyuan, TWN, 33842
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, Spain and Others.

Formosa Laboratories Headlines

No Headlines